Skip to Content

Join the 'HIV Infection' group to help and get support from people like you.

HIV Infection News

Related terms: Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome (AIDS), Acute HIV Infection, Acute Retroviral Syndrome, AIDS, AIDS-Related Complex, Chronic Symptomatic HIV Infection, HIV Infection, Acute, HIV Seroconversion Syndrome, Human Immunodeficiency Virus Infection, Primary HIV Infection, HIV, ARC, Acquired Immunodeficiency Syndrome, HIV/AIDS

Gay Men Less Likely to Have Safe Sex Now: Survey

Posted 9 days ago by Drugs.com

MONDAY, Feb. 13, 2017 – In a sign that powerful new ways to treat and prevent HIV are relaxing attitudes about safer sex, a new survey finds that gay and bisexual men are much less likely to use condoms than they were two decades ago. Men questioned at a Atlanta gay pride event in 2015 – including HIV-positive men – were more likely to say they'd recently had anal sex without a condom compared to men who were questioned at the same event in 2006 and 1997. Although there are signs that the rates of other sexually transmitted infections have increased and the possibility of a drug-resistant strain of the once-deadly virus looms, HIV experts said the condom-less trend may not be as troubling as it appears. "There has been an increase in the understanding that condom-less anal sex is not risky" if men take a drug to prevent HIV infection or take medication if they are already infected, ... Read more

Related support groups: Birth Control, Contraception, Plan B, Emergency Contraception, Mirena, Nexplanon, Sprintec, Provera, NuvaRing, Depo-Provera, Implanon, Ortho Tri-Cyclen, Tri-Sprintec, Microgestin Fe 1/20, Yasmin, Loestrin 24 Fe, Plan B One-Step, Ortho Evra, TriNessa, Mononessa

U.S. Vaccine Guidelines for Flu, HPV Updated

Posted 15 days ago by Drugs.com

TUESDAY, Feb. 7, 2017 – Roll up your sleeves, America. A national advisory panel of the U.S. Centers for Disease Control and Prevention has released its 2017 advisory for recommended shots affecting adults. This year's advisory revises guidance on seasonal flu shots by eliminating nasal flu vaccines and modifying flu-shot advice for people with egg allergy. It also tweaks recommendations for vaccines against human papillomavirus (HPV), hepatitis B and meningococcal disease. Doctors use the annually updated vaccine schedule to ensure that patients receive the right vaccines for their age, medical condition and other risk factors. The entire list includes 13 vaccinations. "All adults need immunizations to help them prevent getting and spreading serious disease that could result in poor health, missed work, medical bills, and not being able to care for family," said the report's lead ... Read more

Related support groups: Obesity, HIV Infection, Autoimmune Disorders, Liver Cirrhosis, Nonalcoholic Fatty Liver Disease, Gardasil, Liver and Pancreatic Disease, Hepatitis B Adult Vaccine, Twinrix, Cervarix, Human Papillomavirus Vaccine, Hepatitis B Prevention, Meningococcal Meningitis Prophylaxis, Human Papillomavirus Prophylaxis, Tetanus Immune Globulin, Influenza Prophylaxis, HyperTET S/D, Vaccination and Prophlaxis, Hepatitis B Prophylaxis, Gardasil 9

Black Americans Still Undertreated for HIV

Posted 19 days ago by Drugs.com

FRIDAY, Feb. 3, 2017 – Although progress has been made, blacks in America are still being hit harder by HIV/AIDS, a new report from the U.S. Centers for Disease Control and Prevention says. The CDC study found that of more than 12,200 black men and women diagnosed with HIV in 2014, nearly 22 percent had progressed to AIDS by the time they were diagnosed. That means diagnosis and treatment is often coming too late. Moreover, among all black Americans with HIV in 2013, only about 54 percent were receiving continuous medical care. Of those getting care, less than half had effectively suppressed the virus. This is far below the National HIV/AIDS Strategy goals of 90 percent of HIV patients in treatment and 80 percent with undetectable HIV by 2020, the study authors noted. "While we have made great progress in HIV prevention among African Americans in recent years, it is clear that we need ... Read more

Related support groups: HIV Infection, Valtrex, Acyclovir, Tamiflu, Valacyclovir, Ribavirin, Pre-Exposure Prophylaxis, Incivek, Zovirax, Truvada, Baraclude, Victrelis, Famciclovir, Famvir, Oseltamivir, Viread, Kaletra, Ribasphere, Tenofovir, Valcyte

Gay Man Infected With HIV Despite Using Preventive Drugs

Posted 1 Feb 2017 by Drugs.com

WEDNESDAY, Feb. 1, 2017 – Doctors report that a gay Canadian man contracted HIV even though he had been taking daily medication to ward off infection. Based on a genetic analysis of the virus, it was determined that the 43-year-old Toronto resident was infected with a strain of HIV that had become resistant to the anti-HIV drug Truvada, said report author Dr. David Knox. He is a doctor with the Maple Leaf Medical Clinic in Toronto. However, HIV experts say this does not mean a completely drug-resistant strain of the virus is on its way, leading to a return of the AIDS crisis of the 1980s and 1990s. "The number of highly resistant strains for Truvada is still very low," said Greg Millett, vice president and director of public policy for amfAR, The Foundation for AIDS Research. "Less than 1 percent of people living with HIV have a highly resistant strain. I do not have a concern that ... Read more

Related support groups: Plan B, Mirena, Nexplanon, Sprintec, Provera, NuvaRing, Depo-Provera, Implanon, Ortho Tri-Cyclen, Tri-Sprintec, Microgestin Fe 1/20, Yasmin, Loestrin 24 Fe, Plan B One-Step, Ortho Evra, TriNessa, Mononessa, Lutera, Ortho Tri-Cyclen Lo, Yaz

Diabetes Risk May Be Higher for HIV-Positive Adults

Posted 31 Jan 2017 by Drugs.com

TUESDAY, Jan. 31, 2017 – People infected with the virus that causes AIDS may be more likely to develop diabetes, new research suggests. In the study, the prevalence of diabetes was almost 4 percent higher among HIV-positive adults than the general population. Researchers examined survey responses of 8,610 HIV-positive participants in the Medical Monitoring Project (MMP). They also analyzed data from about 5,600 people in the general public who took the annual National Health and Nutrition Examination Survey (NHANES). Of the MMP participants, 75 percent were men and nearly 60 percent were aged 45 or older. About 25 percent were obese; about 20 percent also had hepatitis C (HCV); and 90 percent had received antiretroviral therapy within the past year. Of NHANES participants, about half were men aged 45 years and older; 36 percent were obese; and fewer than 2 percent had hepatitis C. The ... Read more

Related support groups: Diabetes, Type 2, Obesity, Metformin, Insulin, Lantus, HIV Infection, Glucophage, Novolog, Glipizide, Humalog, Glyburide, Lantus Solostar, Levemir, Glimepiride, Pre-Exposure Prophylaxis, Incivek, Novolin R, Amaryl, Novolin N, Humulin N

Many With Mental Illness Miss Out on HIV Tests

Posted 20 Jan 2017 by Drugs.com

THURSDAY, Jan. 19, 2017 – People with severe mental illness are only slightly more likely to be screened for HIV than those in the general population, a new study finds. And that's true even though they're at higher risk for infection with the AIDS-causing virus, the researchers added. The study included nearly 57,000 Medicaid patients in California. They were between the ages of 18 and 67. They were all taking medications to treat bipolar disorder, schizophrenia or major depression with psychosis. Just under 7 percent had HIV testing, compared with 5 percent of the state's general population in 2011, according to the study. The authors said their findings suggest a missed opportunity to treat HIV infection early in people with severe mental illness. The risk of HIV may be up to 15 percent higher in people with severe mental illness than in the general population, the researchers said. ... Read more

Related support groups: Depression, Anxiety, Bipolar Disorder, Anxiety and Stress, Obsessive Compulsive Disorder, Major Depressive Disorder, Attention-Deficit Hyperactivity Disorder (ADHD), Post Traumatic Stress Disorder, Schizophrenia, Schizoaffective Disorder, HIV Infection, Psychiatric Disorders, Asperger Syndrome, Drug Psychosis

Can HIV Drugs Boost Syphilis Risk?

Posted 17 Jan 2017 by Drugs.com

MONDAY, Jan. 16, 2017 – Gay and bisexual men taking antiretroviral drugs to treat HIV infection may be at increased risk for syphilis, new research contends. Based on a review of available evidence, the investigators concluded that the drugs may boost susceptibility to the bacterium that causes syphilis, although the study did not prove cause-and-effect. The finding might explain why new and repeat cases of syphilis in gay and bisexual men have risen sharply compared to other sexually transmitted infections over the past decade, the researchers wrote. The study team was led by Dr. Michael Rekart, from the University of British Columbia's School of Population and Public Health in Vancouver. The findings were published in the Jan. 16 issue of the journal Sexually Transmitted Infections. The authors of an editorial that accompanied the study said the theory is "intriguing" and "warrants ... Read more

Related support groups: HIV Infection, Sexually Transmitted Diseases, Valtrex, Acyclovir, Tamiflu, Valacyclovir, Ribavirin, Pre-Exposure Prophylaxis, Incivek, Zovirax, Syphilis, Baraclude, Famciclovir, Victrelis, Famvir, Oseltamivir, Viread, Kaletra, Ribasphere, Tenofovir

HIV May Double Odds of Heart Attack

Posted 22 Dec 2016 by Drugs.com

WEDNESDAY, Dec. 21, 2016 – As people with HIV are living longer, new concerns are cropping up, such as a risk for heart attack up to two times greater than for people without the AIDS-causing virus, a new study reports. Those increased odds are seen even in people whose virus has been suppressed to undetectable levels in the blood with antiretroviral drugs, the researchers said. There are several reasons for this higher risk, said lead researcher Dr. Matthew Feinstein, a cardiology fellow at Northwestern University Feinberg School of Medicine in Chicago. "A key factor appears to be chronic HIV-associated inflammation that persists even when there is no detectable virus in the blood," he said. Feinstein explained that the heart disease and stroke risk is higher "because the virus maintains a reservoir in the body's tissues, driving a chronic inflammatory and immune response that can ... Read more

Related support groups: Heart Attack, HIV Infection, Pre-Exposure Prophylaxis, Myocardial Infarction, Myocardial Infarction - Prophylaxis, Post MI Syndrome, Family History of Myocardial Infarction

Doctors Seeing More HIV Patients With Multidrug Resistance

Posted 1 Dec 2016 by Drugs.com

THURSDAY, Dec. 1, 2016 – A significant number of people with HIV have strains of the AIDS-causing virus that are resistant to both older and newer drugs, researchers report. The researchers looked at 712 HIV patients worldwide whose infection was not controlled by antiretroviral drugs. They found that 16 percent of patients whose infection was resistant to modern drugs had HIV mutations linked with resistance to older drugs called thymidine analogues. Among patients whose HIV had this mutation, 80 percent were also resistant to tenofovir, the main drug in most modern HIV treatment and prevention programs, the researchers reported. The findings were published in the Nov. 30 issue of The Lancet Infectious Diseases journal. "We were very surprised to see that so many people were resistant to both drugs, as we didn't think this was possible," study lead author Ravi Gupta, of University ... Read more

Related support groups: Harvoni, HIV Infection, Atripla, Sovaldi, Pre-Exposure Prophylaxis, Incivek, Truvada, Stribild, Complera, Triumeq, Baraclude, Victrelis, Genvoya, Epclusa, Zepatier, Sofosbuvir, Viread, Kaletra, Viekira Pak, Norvir

Use of Needle Exchange Programs Up Dramatically in 10 Years: CDC

Posted 30 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 30, 2016 – Although there was a significant increase in the use of syringe services programs (SSPs) – more commonly known as needle exchange programs – across the United States over the past decade, many injection drug users don't always use sterile needles, a federal government report says. Previously used needles put drug users at risk for infectious diseases such as HIV and hepatitis B and C, the report noted. Needle exchange programs provide sterile needles and syringes to injection drug users. These programs also refer drug users to prevention, care and treatment services. Researchers from the U.S. Centers for Disease Control and Prevention looked at data from injection drug users in 22 cities with high rates of HIV. In 2015, 54 percent of injection drug users said they used a needle exchange program in the past year. That was up significantly compared to the 36 ... Read more

Related support groups: Opiate Dependence, Hepatitis C, HIV Infection, Drug Dependence, Hepatitis B, Pre-Exposure Prophylaxis, Substance Abuse, Toxic Reactions Incl Drug and Substance Abuse, Hepatitis B Prevention, Exposure to Hepatitis B Virus, Hepatitis B Prophylaxis

U.S. Death Toll From Infectious Diseases Unchanged: Study

Posted 22 Nov 2016 by Drugs.com

TUESDAY, Nov. 22, 2016 – The war against infectious diseases – medicine versus microbes – has been holding steady, with the U.S. death rate from these diseases about the same now as it was in 1980, new research says. But some of the specific disease threats have changed over the years, the study authors noted. Researchers found that the national death rate from infections stood at almost 46 deaths per 100,000 people in 2014. That compared with 42 per 100,000 in 1980. There were some major shifts during that time, however. The overall death rate went as high as 63 per 100,000 in 1995, owing to the HIV/AIDS epidemic, according to the study. AIDS deaths declined from then on, with the introduction of the "drug cocktails" that have turned HIV into a manageable chronic disease. But while there was progress against HIV, deaths from pneumonia and flu complications held steady over the ... Read more

Related support groups: Bacterial Infection, Influenza, Pneumonia, HIV Infection, Clostridial Infection, Viral Infection, West Nile Virus, Prevention of Clostridium Difficile Infection Recurrence, Adjunct to Antibiotic Therapy

ViiV Healthcare Announces FDA Approval of Selzentry (maraviroc) for Use in Children and Adolescents Living With HIV

Posted 17 Nov 2016 by Drugs.com

Research Triangle Park, NC — On November 4, 2016, ViiV Healthcare received approval from the U.S. Food and Drug Administration (FDA) to market Selzentry for the treatment of only CCR5-tropic HIV-1 infection, in combination with other antiretroviral agents, in pediatric patients 2 years of age or older who weigh at least 10 kilograms (kg).[1] Selzentry is a first-in-class CCR5 co-receptor antagonist designed to inhibit entry into the immune system’s CD4+ T-cells by CCR5-tropic HIV-1. Selzentry is not recommended in patients with dual/mixed- or CXCR4-tropic HIV-1. In addition to the 150 milligram (mg) and 300 mg Selzentry tablets currently available, new 25 mg and 75 mg tablets and a 20 mg per milliliter (mL)oral solution will be available in January 2017. The dose of Selzentry in pediatric patients 2 years of age and older should be based on the patient’s body weight and the drug inter ... Read more

Related support groups: HIV Infection, Selzentry, Maraviroc

Can Time-Release Capsules Replace Daily Pills?

Posted 16 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 16, 2016 – A new type of drug capsule might one day replace the need to take medicines every day, but so far it has only been tested in pigs, researchers report. A capsule that contains a six-armed star containing drugs can remain in the stomach and release its medication over time. That means instead of taking daily medication, patients would only have to swallow one capsule weekly or monthly, the researchers said. "We have the potential for an ultra-long capsule for medications that folks are currently taking once or twice or three times a day – that can now be given once a week or once a month," said researcher Dr. Giovanni Traverso. He is an instructor in the division of gastroenterology at Brigham and Women's Hospital in Boston. "This can make life a lot easier, because patients are more likely to take a medication when it's dosed once a week versus once a day," ... Read more

Related support groups: Schizophrenia, Schizoaffective Disorder, HIV Infection, Renal Failure, Alzheimer's Disease, Pre-Exposure Prophylaxis, Chronic Kidney Disease, Hyperphosphatemia of Renal Failure

Drug Combo Shows Early Promise for Remission of HIV

Posted 10 Nov 2016 by Drugs.com

THURSDAY, Nov. 10, 2016 – Animal research with an experimental two-drug therapy could hold clues for creating long-term HIV remission in people living with the virus, a new report says. The goal: to free patients from the need to take anti-HIV pills each day. Researchers combined an experimental vaccine with an immune-stimulating drug to create a one-two punch that caused a similar virus to become undetectable in three out of nine test monkeys, said senior author Dr. Dan Barouch. He's director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center in Boston. "Both of these components already are in clinical trials being conducted separately," Barouch said. "We hope to evaluate the combination in humans, and we plan to do further animal studies as well. The experimental vaccine, called Ad26/MVA, aims to help the immune system target HIV. The ... Read more

Related support groups: HIV Infection, Pre-Exposure Prophylaxis, Diagnosis and Investigation

Antibodies May Hold Key to HIV Suppression

Posted 10 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 9, 2016 – Antibodies may keep the HIV virus in check and one day let patients stop taking antiretroviral drugs, two new preliminary trials suggest. Researchers tried to quell HIV in 23 patients with infusions of an anti-HIV antibody known as VRC01. The antibody was safe and repressed blood levels of HIV for a short time before the virus reappeared, the researchers said. HIV is the virus that can lead to AIDS. "We were not expecting that we were going to see a prolonged repression, because it was only a single antibody," said co-study author Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases. The next phase is to infuse two or three antibodies intermittently, and see if antiretroviral drugs can be withdrawn permanently, he explained. After regular intravenous infusions of VRC01, participants in the U.S. National Institutes of ... Read more

Related support groups: HIV Infection, Valtrex, Acyclovir, Valacyclovir, Ribavirin, Pre-Exposure Prophylaxis, Incivek, Zovirax, Baraclude, Famciclovir, Victrelis, Famvir, Viread, Kaletra, Valcyte, Entecavir, Norvir, Copegus, Tenofovir, Ribasphere

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Pre-Exposure Prophylaxis, Viral Infection

Related Drug Support Groups

Atripla, Truvada, Stribild, Triumeq, Complera, Genvoya, Viread, Kaletra, tenofovir, view more... Norvir, lamivudine, Prezista, nevirapine, Privigen, Reyataz, Combivir, ritonavir, Lexiva, abacavir, Norvir Soft Gelatin, Tivicay, Sandoglobulin, Epivir, zidovudine, immune globulin intravenous, Sustiva, Octagam, Trizivir, Odefsey, Descovy, indinavir, efavirenz, didanosine, lamivudine / zidovudine, Epzicom, atazanavir, Carimune, Retrovir, Ziagen, Agenerase, Fuzeon, dolutegravir, Edurant, Prezcobix, raltegravir, Intelence, nelfinavir, stavudine, darunavir, Telzir, Carimune NF, amprenavir, abacavir / dolutegravir / lamivudine, Isentress, Vitekta, Venoglobulin-S 5%, Evotaz, Dutrebis, Venoglobulin-S 10%, Tybost, Selzentry, Gammagard S / D, Viramune XR, Panglobulin, Gamimune, Panglobulin NF, Iveegam En, Gamimune N 10%, Gamimune N 5%, Zerit XR, Gammar IV, Gammaplex, Polygam S / D, Gammar-P IV, Crixivan, etravirine, zalcitabine, tipranavir, saquinavir, emtricitabine / lopinavir / ritonavir / tenofovir, emtricitabine / nelfinavir / tenofovir, cobicistat / elvitegravir / emtricitabine / tenofovir, emtricitabine / rilpivirine / tenofovir, rilpivirine, maraviroc, lopinavir / ritonavir, delavirdine, abacavir / lamivudine / zidovudine, abacavir / lamivudine, efavirenz / emtricitabine / tenofovir, emtricitabine, fosamprenavir, enfuvirtide, emtricitabine / tenofovir, elvitegravir, cobicistat, Viramune, Viracept, Epivir-HBV, Fortovase, Invirase, Hivid, Aptivus, Zerit, Emtriva, Videx EC, lamivudine / raltegravir, cobicistat / darunavir, atazanavir / cobicistat, cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide, emtricitabine / rilpivirine / tenofovir alafenamide, Videx, Rescriptor, emtricitabine / tenofovir alafenamide, Flebogamma